Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment.

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design ...

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...

LONDON, March 31, 2025 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, today announced it has raised $600 Million in its first external funding round.

Isomorphic will use the windfall to fund development of its next-generation artificial intelligence drug design model, the company announced in a March 31 release. The AI biotech is also looking ...

Isomorphic Labs, Google’s artificial intelligence drug business, raised $600 million in its first external funding round, the company said on Monday.

Drug design and development company Isomorphic Labs announced it raised $600 million in its first external funding round. Thrive Capital led the round, with participation from GV (Google Ventures) and ...

According to Murdoch, Isomorphic Labs’ team is currently “collaborating with AI to design drugs for cancer,” and is already “staffing up” for its first human clinical trials.

A version of this article appears in print on April 1, 2025, Section B, Page 3 of the New York edition with the headline: Google’s A.I. Drug Design Lab, Isomorphic, Raises $600 Million.

Isomorphic Labs founder and CEO, Sir Demis Hassabis, PhD “This funding will further turbocharge the development of our next-generation AI drug design engine, help us advance our own programs ...

Alphabet’s secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind’s chief ...

Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline. LONDON ...